Dawn Matthews

473 total citations
11 papers, 260 citations indexed

About

Dawn Matthews is a scholar working on Radiology, Nuclear Medicine and Imaging, Psychiatry and Mental health and Physiology. According to data from OpenAlex, Dawn Matthews has authored 11 papers receiving a total of 260 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Psychiatry and Mental health and 4 papers in Physiology. Recurrent topics in Dawn Matthews's work include Dementia and Cognitive Impairment Research (5 papers), Alzheimer's disease research and treatments (4 papers) and Medical Imaging Techniques and Applications (3 papers). Dawn Matthews is often cited by papers focused on Dementia and Cognitive Impairment Research (5 papers), Alzheimer's disease research and treatments (4 papers) and Medical Imaging Techniques and Applications (3 papers). Dawn Matthews collaborates with scholars based in United States, Austria and Australia. Dawn Matthews's co-authors include Randolph D. Andrews, Ana Lukić, Raj C. Shah, Howard Fillit, Jerry R. Colca, Debra Fleischman, James T. VanderLugt, Ana W. Capuano, P. David Mozley and Ana C. Pereira and has published in prestigious journals such as Brain, JNCI Journal of the National Cancer Institute and Alzheimer s & Dementia.

In The Last Decade

Dawn Matthews

11 papers receiving 258 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dawn Matthews United States	7	96	68	48	47	45	11	260
Emily J. Gilles United States	11	176 1.8×	86 1.3×	25 0.5×	61 1.3×	21 0.5×	17	403
Baayla D.C. Boon Netherlands	12	187 1.9×	117 1.7×	17 0.4×	66 1.4×	23 0.5×	25	368
Padmashree S. Tirumalai United States	7	47 0.5×	103 1.5×	70 1.5×	32 0.7×	20 0.4×	9	366
Morgan Robinson Canada	7	184 1.9×	156 2.3×	15 0.3×	13 0.3×	53 1.2×	14	377
Jorge Trejo‐Lopez United States	7	153 1.6×	93 1.4×	11 0.2×	12 0.3×	42 0.9×	27	366
Maëva Dhaynaut United States	10	124 1.3×	68 1.0×	8 0.2×	77 1.6×	20 0.4×	23	343
Justyna M.C. Bahl Denmark	9	164 1.7×	127 1.9×	18 0.4×	13 0.3×	38 0.8×	12	336
Lan Ye Germany	9	252 2.6×	160 2.4×	10 0.2×	37 0.8×	40 0.9×	16	368
Igor C. Fontana Sweden	8	158 1.6×	98 1.4×	9 0.2×	16 0.3×	32 0.7×	14	304
Michael Uebele Germany	5	114 1.2×	90 1.3×	29 0.6×	75 1.6×	29 0.6×	6	576

Countries citing papers authored by Dawn Matthews

Since Specialization

Citations

This map shows the geographic impact of Dawn Matthews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn Matthews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn Matthews more than expected).

Fields of papers citing papers by Dawn Matthews

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn Matthews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn Matthews. The network helps show where Dawn Matthews may publish in the future.

Co-authorship network of co-authors of Dawn Matthews

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn Matthews. A scholar is included among the top collaborators of Dawn Matthews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn Matthews. Dawn Matthews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Matthews, Dawn, Jefferson W. Kinney, Aaron Ritter, et al.. (2024). Relationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in mild to moderate Alzheimer's disease patients. Alzheimer s & Dementia Translational Research & Clinical Interventions. 10(3). e12490–e12490. 6 indexed citations

Ahmed, Kamran, et al.. (2024). Improving event prediction using general practitioner clinical judgement in a digital risk stratification model: a pilot study. BMC Medical Informatics and Decision Making. 24(1). 382–382. 2 indexed citations

Epelbaum, Stéphane, Ninon Burgos, Michael Canney, et al.. (2022). Pilot study of repeated blood-brain barrier disruption in patients with mild Alzheimer’s disease with an implantable ultrasound device. Alzheimer s Research & Therapy. 14(1). 40–40. 53 indexed citations

Raikes, Adam C., Gerson D. Hernandez, Dawn Matthews, et al.. (2022). Exploratory imaging outcomes of a phase 1b/2a clinical trial of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: Structural effects and functional connectivity outcomes. Alzheimer s & Dementia Translational Research & Clinical Interventions. 8(1). e12258–e12258. 13 indexed citations

Matthews, Dawn, Aaron Ritter, Ronald G. Thomas, et al.. (2021). Rasagiline effects on glucose metabolism, cognition, and tau in Alzheimer's dementia. Alzheimer s & Dementia Translational Research & Clinical Interventions. 7(1). e12106–e12106. 32 indexed citations

Matthews, Dawn, Xiangling Mao, Caroline S. Jiang, et al.. (2021). Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer’s disease. Brain. 144(12). 3742–3755. 68 indexed citations

Hernandez, Gerson D., Wendy J. Mack, Naoko Kono, et al.. (2020). Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: A single and multiple ascending dose phase 1b/2a clinical trial. Alzheimer s & Dementia Translational Research & Clinical Interventions. 6(1). e12107–e12107. 26 indexed citations

Obuchowski, Nancy A., P. David Mozley, Dawn Matthews, et al.. (2018). Statistical Considerations for Planning Clinical Trials with Quantitative Imaging Biomarkers. JNCI Journal of the National Cancer Institute. 111(1). 19–26. 11 indexed citations

Smith, Anne M., Dawn Matthews, & Randolph D. Andrews. (2017). Assessment of PET Amyloid Quantification Differences by Varying the Reconstruction Protocol. 1–6. 1 indexed citations

10.

Shah, Raj C., Dawn Matthews, Randolph D. Andrews, et al.. (2014). An Evaluation of MSDC-0160, A Prototype mTOT Modulating Insulin Sensitizer, in Patients with Mild Alzheimer’s Disease. Current Alzheimer Research. 11(6). 564–573. 46 indexed citations

11.

Mosconi, Lisa, Dawn Matthews, Mark E. Schmidt, & Randolph Andrews. (2012). P2‐228: Characterizing brain amyloid changes using PiB‐PET: Progression, clinical correlates, PiB status and optimized sampling. Alzheimer s & Dementia. 8(4S_Part_9). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact